Biosphere tenant Iksuda Therapeutics enters licensing agreement with LegoChem Biosciences
LegoChem Biosciences and Iksuda enter Licensing Agreement for Antibody Drug Conjugate program Iksuda gains… Continue Reading Biosphere tenant Iksuda Therapeutics enters licensing agreement with LegoChem Biosciences


